Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors

We report four cases of successful treatment with certolizumab pegol (CZP) of rheumatoid arthritis (RA) patients with persistent inflamed residual mono- or oligosynovitis resistant to prior TNF-α inhibitors. Although the patients were in a moderate disease activity, a low activity, or a remission of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Rheumatol
Autors principals: Koarada, Syuichi, Tsuboi, Masahiko, Komine, Mitsunori, Nakao, Yoshinobu, Tokuda, Yukiko, Ono, Yukihide, Tashiro, Satoko, Maruyama, Akihito, Ono, Nobuyuki, Ohta, Akihide, Tada, Yoshifumi
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4584239/
https://ncbi.nlm.nih.gov/pubmed/26451269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/348614
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars